Filing Details
- Accession Number:
- 0001213900-21-064007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-07 18:44:35
- Reporting Period:
- 2021-12-06
- Accepted Time:
- 2021-12-07 18:44:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1811612 | T Matthew David | C/O Cormedix Inc. 300 Connell Drive Suite 4200 Berkeley Heights NJ 07922 | Interim Ceo And Cfo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-06 | 1,000 | $4.50 | 3,150 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy Common Stock) | $5.56 | 2031-11-01 | 125,000 | 125,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $8.32 | 2031-01-11 | 80,000 | 80,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $5.63 | 2030-05-11 | 125,000 | 125,000 | Direct | |
Common Stock | Stock Option (Right to Buy Common Stock) | $4.08 | 2030-05-11 | 125,000 | 125,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2031-11-01 | 125,000 | 125,000 | Direct |
2031-01-11 | 80,000 | 80,000 | Direct |
2030-05-11 | 125,000 | 125,000 | Direct |
2030-05-11 | 125,000 | 125,000 | Direct |
Footnotes
- These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
- These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
- These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.